Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/17/2014US20140200191 Carbohydrate-lipid constructs and their use in preventing or treating viral infection
07/17/2014US20140200189 Artoni i to treat resistant infectious staphylococcus aureus
07/17/2014US20140200188 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
07/17/2014US20140200183 Treatment of cardiac arrhythmias
07/17/2014US20140200176 Nutritional compositions containing magnesium threonate and uses thereof
07/17/2014US20140200175 Suppression of toxin production of clostridium difficle
07/17/2014US20140199469 Sustained-release tablet and process for preparing the same
07/17/2014US20140199418 Herpes treatment
07/17/2014US20140199417 Antihistamines Combined with Dietary Supplements for Improved Health
07/17/2014US20140199415 Pharmaceutical combination comprising a cip2a silencing agent for use in the treatment of a hyperproliferative disorder, preferably one with impaired p53 function
07/17/2014US20140199414 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
07/17/2014US20140199413 Melatonin and an antimicrobial or antibacterial agent for the treatment of acne
07/17/2014US20140199412 Treating inflammation with a binding system
07/17/2014US20140199410 Edible brown algae extract with a low iodine content
07/17/2014US20140199408 Therapeutic stem cell nutrient composition and uses thereof
07/17/2014US20140199405 Method for treating cancer based on mutation status of k-ras
07/17/2014US20140199404 Method for treating cancer based on level of a nucleoside transporter
07/17/2014US20140199403 Methods of treating pancreatic cancer
07/17/2014US20140199401 Extended release pharmaceutical compositions of fesoterodine
07/17/2014US20140199400 Active Agent Loaded Uniform, Rigid, Spherical, Nanoporous Calcium Phosphate Particles and Methods of Making and Using the Same
07/17/2014US20140199397 Benzoyl Peroxide Microparticle Process
07/17/2014US20140199395 Novel formulation of meloxicam
07/17/2014US20140199394 Controlled release hydrocodone
07/17/2014US20140199393 Controlled release pharmaceutical compositions comprising a fumaric acid ester
07/17/2014US20140199392 Controlled release pharmaceutical compositions comprising a fumaric acid ester
07/17/2014US20140199391 Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compound
07/17/2014US20140199390 Controlled release pharmaceutical compositions comprising a fumaric acid ester
07/17/2014US20140199388 Controlled release pharmaceutical compositions comprising a fumaric acid ester
07/17/2014US20140199387 Controlled release pharmaceutical compositions comprising a fumaric acid ester
07/17/2014US20140199386 Controlled release pharmaceutical compositions comprising a fumaric acid ester
07/17/2014US20140199382 Stable pharmaceutical compositions of an s1p receptor agonist
07/17/2014US20140199381 Core-shell microspheres
07/17/2014US20140199380 Pharmaceutical composition comprising an algae adapted to increase the efficacy of an enzymatic inhibitor
07/17/2014US20140199376 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
07/17/2014US20140199375 Combination therapy for skin disorders
07/17/2014US20140199374 Methods for preparation of lipid-encapsulated therapeutic agents
07/17/2014US20140199373 Novel Formulations and Methods for Treating Dermatological Disorders or Diseases
07/17/2014US20140199372 Microbial growth factors
07/17/2014US20140199367 Topical Transdermal Method for Delivering Nutrients Through the Skin for Expeditied Wound Healing and Skin Rejuvenation
07/17/2014US20140199366 Sustained release intraocular implants and methods for treating ocular neuropathies
07/17/2014US20140199365 Resorbable stents which contain a magnesium alloy
07/17/2014US20140199364 Drug loaded fibers
07/17/2014US20140199349 Ph-sensitive hyaluronic acid derivative and uses thereof
07/17/2014US20140199347 Adjuvant compositions with 4-1bbl
07/17/2014US20140199342 Composition and method to alleviate joint pain using algae based oils
07/17/2014US20140199329 Methods for treating and preventing neutrophil-derived net toxicity and thrombosis
07/17/2014US20140199323 Monoclonal Antibody
07/17/2014US20140199313 Process for the Production of Fine Chemicals
07/17/2014US20140199300 Combination therapy for the treatment of cd19+ b-cell malignancies symptoms comprising an anti-cd1 maytansinoid immunoconjugate and rituzimab
07/17/2014US20140199298 Combination treatment of cancer comprising egfr/her2 inhibitors
07/17/2014US20140199297 Triterpene glycoside and triterpene compositions and methods of using same
07/17/2014US20140199296 Cancer Drug and Uses
07/17/2014US20140199292 Compositions and methods for inhibiting tumor development caused by chemotherapy induced senescence
07/17/2014US20140199291 Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml)
07/17/2014US20140199289 Use of matrix metalloproteinase inhibitors to treat tuberculosis
07/17/2014US20140199287 Non-neurotoxic plasminogen activating factors for treating of stroke
07/17/2014US20140199285 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs
07/17/2014US20140199282 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
07/17/2014US20140199277 Methods of Treatment of Retinal Degeneration Diseases
07/17/2014US20140199270 Methods and compositions to reduce fat gain, promote weight loss in mammals
07/17/2014US20140199267 Methods for ameliorating symptoms or conditions caused by stress
07/17/2014US20140199265 Nutritional compositions containing a neurologic component and uses thereof
07/17/2014US20140199264 Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases
07/17/2014US20140199263 Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
07/17/2014US20140199261 Method of reducing multi-drug resistance using inositol tripyrophosphate
07/17/2014US20140199260 Compositions and methods for the treatment of hiv
07/17/2014US20140199244 Controlled release system
07/17/2014US20140199241 Liposomes comprising polymer-conjugated lipids and related uses
07/17/2014US20140199236 Androgen receptor modulator and uses thereof
07/17/2014US20140199234 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
07/17/2014US20140199233 Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor
07/17/2014US20140199232 Targeted Therapeutic Nanoparticles
07/16/2014EP2754714A1 Inhibitory oligonucleotides and their use in therapy
07/16/2014EP2754710A1 Method for cultivating seaweed and method for producing alginic acid-containing composition
07/16/2014EP2754660A1 Pyridazinon derivatives
07/16/2014EP2754659A1 4-substituted-(3-substituted-1h-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof
07/16/2014EP2754656A1 Androgen receptor modulating compounds
07/16/2014EP2754655A2 Novel compound having angiogenesis inhibitory activity, method for preparing same, and pharmaceutical composition comprising same
07/16/2014EP2754653A2 Azetidine derivative and antidepressant composition containing same
07/16/2014EP2754454A2 Non-steroidal anti-inflammatory drug derivatives
07/16/2014EP2754448A2 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury
07/16/2014EP2754444A1 Composition for improving in vivo metabolism parameter
07/16/2014EP2754443A1 Misoprostol for the induction of labour
07/16/2014EP2754442A1 Misoprostol for the induction of labour
07/16/2014EP2754441A2 Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives
07/16/2014EP2754440A1 Medicinal agent for treating amyotrophic lateral sclerosis or preventing progression of phase of amyotrophic lateral sclerosis
07/16/2014EP2754439A2 Use of aminolevulinic acid derivatives
07/16/2014EP2753696A1 The mirna-212/132 family as a therapeutic target
07/16/2014EP2753695A1 Strategies for prevention and/or treatment of diseases based on cd40 silencing
07/16/2014EP2753632A1 Neuroactive steroids, compositions, and uses thereof
07/16/2014EP2753630A1 4-methylcatechol derivatives und use thereof
07/16/2014EP2753628A1 Platinum anticancer agents
07/16/2014EP2753626A1 Llp2a-bisphosphonate conjugates for osteoporosis treatment
07/16/2014EP2753623A1 Gamma secretase inhibitors
07/16/2014EP2753618A1 Heterocyclic-substitued benzofuran derivatives and methods of use thereof for the treatment of viral diseases
07/16/2014EP2753617A1 Piperazine- substituted benzothiophene derivatives as antipsychotic agents
07/16/2014EP2753616A1 Crystalline forms of afatinib di-maleate
07/16/2014EP2753615A1 Benzonitrile derivatives as kinase inhibitors
07/16/2014EP2753613A1 Derivatives of xanthone compounds
07/16/2014EP2753611A1 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 7860